Patrick D. Hsu
Innovative Genomics Institute
Patrick D. Hsu is an American bioengineer, entrepreneur, and investor specializing in CRISPR, machine learning, synthetic biology, and gene therapy. He is an assistant professor of pathology at Stanford University and a co-founder of Arc Institute, a research organization focused on accelerating biomedical discovery. He is a member of the board of directors of Notion and the scientific advisory board of Amgen.
Read biography ↓Biography, research & contributions
Patrick D. Hsu is an American bioengineer, entrepreneur, and investor specializing in CRISPR, machine learning, synthetic biology, and gene therapy. He is an assistant professor of pathology at Stanford University and a co-founder of Arc Institute, a research organization focused on accelerating biomedical discovery. He is a member of the board of directors of Notion and the scientific advisory board of Amgen.
Affiliation
Innovative Genomics Institute
Top Publications
- Multiplex Genome Engineering Using CRISPR/Cas Systems (2013) - 16,064 citations
- Genome engineering using the CRISPR-Cas9 system (2013) - 12,033 citations
- Development and Applications of CRISPR-Cas9 for Genome Engineering (2014) - 6,009 citations
- DNA targeting specificity of RNA-guided Cas9 nucleases (2013) - 5,041 citations
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity (2013) - 3,417 citations
At a glance
- Full name
- Patrick D. Hsu
- ORCID
- 0000-0002-9380-2648
- OpenAlex ID
- https://openalex.org/A5060049408
Research interests
- CRISPR and Genetic Engineering, Drug Transport and Resistance Mechanisms, Cancer Treatment and Pharmacology, Microtubule and mitosis dynamics, RNA regulation and disease
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Multiplex Genome Engineering Using CRISPR/Cas Systems ↗2013 · Science16,064OpenAlex citations
- Genome engineering using the CRISPR-Cas9 system ↗2013 · Nature Protocols12,033OpenAlex citations
- 6,009OpenAlex citations
- DNA targeting specificity of RNA-guided Cas9 nucleases ↗2013 · Nature Biotechnology5,041OpenAlex citations
- 3,417OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Multiplex Genome Engineering Using CRISPR/Cas Systems ↗2013 · Science
- Genome engineering using the CRISPR-Cas9 system ↗2013 · Nature Protocols
- DNA targeting specificity of RNA-guided Cas9 nucleases ↗2013 · Nature Biotechnology
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 23:38:27
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.